Table 3. Characteristics of the two groups that have the spot sign in the ventricle and the others.
| Total (n=26) | Spot sign in a ventricle (N=8) Group A | Spot sign in the others (N=18) Group B | p-value | |
|---|---|---|---|---|
| Demographic | ||||
| Age (range) | 46.9 (15-80) years | 50.4 (18-80) years | 45.3 (15-70) years | 0.487 |
| Male sex | 14 (53.8%) | 4 (28.6%) | 10 (71.4%) | 1.000 |
| Clinical factor | ||||
| Hypertension | 12 (46%) | 4 (33.3%) | 8 (66.7%) | 1.000 |
| Diabetes mellitus | 7 (26.9%) | 3 (42.9%) | 4 (57.1%) | 0.635 |
| Dyslipidemia | 5 (19.2%) | 0 (0%) | 5 (100%) | 0.281 |
| Antiplatelet use | 7 (26.9%) | 3 (42.9%) | 4 (57.1%) | 0.635 |
| GCS score (±SD) | 11 (±0.7) | 10.6 (±1.3) | 11.2 (±0.8) | 0.732 |
| SBP (±SD) | 149.8 (±7.7) mmHg | 128 (±9.7) mmHg | 156.4 (±9.6) mmHg | 0.079 |
| DBP (±SD) | 84 (±4.0) mmHg | 75.4 (±8.7) mmHg | 87.9 (±4.1) mmHg | 0.325 |
| Platelets (±SD) | 245.7(±13.3) ×109 cells/L | 231.4(±26.9) ×109 cells/L | 252.1 (±15.4) ×109 cells/L | 0.304 |
| INR (±SD) | 1.03 (±0.09) | 1.04 (±0.03) | 1.02 (±0.02) | 0.289 |
| aPTT (±SD) | 23.9 (±0.94) sec | 22.5 (±1.21) sec | 24.5 (±1.24) sec | 0.359 |
| DSA result | ||||
| Negative | 17 (65.4%) | 3 (17.6%) | 14 (82.4%) | 0.078 |
| pseudoaneurysm | 7 (26.9%) | 5 (71.4%) | 2 (28.6%) | 0.014 |
| DVA | 2 (7.7%) | 0 (0%) | 2 (100%) | 1.000 |
| Treatment | ||||
| Surgical | 13 (50.0%) | 1 (7.7%) | 12 (92.3%) | 0.030 |
| endovascular | 3 (11.1%) | 3 (100%) | 0 (0%) | 0.022 |
| Conservative care | 10 (37%) | 4 (40.0%) | 6 (60.0%) | 0.664 |
Abbreviations: SD, Standard deviation; GCS, Glasgow coma scale; SBP, Systolic blood pressure; DBP, Diastolic blood pressure; DVA, Developmental venous anomaly.